Key Highlights
- Intel shares fell 6.1% Monday, finishing at $103.12, worse than the Nasdaq’s 1.55% loss
- Chip sector weakness pressured competitors like AMD and Micron as well
- Company unveiled €5 billion Irish campus expansion focused on AI and foundry growth
- Q2 results scheduled for July 23, with Street expecting $0.21 EPS and $14.35 billion revenue
- Analyst consensus remains “Hold” with average target price of $100.77
Intel (INTC) finished Monday’s session at $103.12, representing a 6.1% decline from the previous close of $109.84. Trading volume reached approximately 99.5 million shares, falling about 18% short of typical daily activity.
The semiconductor giant’s losses exceeded broader market declines. The S&P 500 retreated 0.79% during the same period, while the Nasdaq Composite declined 1.55%.
Intel wasn’t alone in the downturn. Risk-off sentiment throughout the semiconductor industry dragged down rival companies such as AMD and Micron during Monday’s trading.
Market participants are now focused on upcoming results. Intel will release quarterly figures on July 23, 2026, with Wall Street forecasting earnings per share of $0.21—representing a 310% increase compared to the year-ago period. Revenue estimates stand at $14.35 billion, marking an 11.58% year-over-year advance.
Full-year projections call for EPS of $1.06 and revenue of $58.36 billion, indicating growth rates exceeding 152% and 10%, respectively.
Despite Monday’s decline, Intel shared encouraging developments this week. The chipmaker revealed plans for a €5 billion investment to enhance its Irish manufacturing facilities, targeting expanded production of AI chips, Xeon processors, and foundry services.
Wall Street Remains Divided on Outlook
Street sentiment remains measured. The overall rating stands at “Hold” with a mean price objective of $100.77—modestly under Monday’s closing price.
HC Wainwright maintains the most optimistic view with a $150 target. JPMorgan carries an “underweight” rating alongside a $45 price objective. Wells Fargo assigns an “equal weight” designation with a $110 target.
Among covering analysts, 15 recommend Buy, 28 suggest Hold, and 4 advise Sell. Two analysts rate the stock as Strong Buy.
Intel trades at a forward P/E of 103.62, significantly exceeding the sector average of 57.17. This premium valuation comes as the company navigates foundry execution hurdles.
Zacks Research ranks Intel at #1 (Strong Buy), noting the consensus EPS projection has climbed 0.84% during the last month.
Headwinds Persist for the Chipmaker
Competitive dynamics remain a focal point. Analysts have highlighted potential challenges if Intel enters memory manufacturing, where it would compete against established players like SK Hynix. AMD continues capturing data center market share.
Insider activity has drawn scrutiny. Executive Vice President Boise April Miller offloaded more than 40,000 shares at $99.53 on May 1st, reducing her holdings by 27.7%. Significant insider disposals typically attract market attention.
Institutional investors maintain substantial positions. Vanguard controls over 404 million shares, State Street owns 208 million, and Morgan Stanley boosted its stake by 20.4% during Q4. Institutional ownership totals 64.53% of outstanding shares.
Intel’s 50-day moving average registers at $118.67, while the 200-day average sits at $73.89—illustrating the stock’s significant movement over the trailing twelve months.
The company’s Q1 performance, disclosed April 23, delivered $0.29 EPS, substantially exceeding the $0.01 Street estimate. Revenue of $13.58 billion similarly surpassed the $12.32 billion consensus.
Management guided Q2 to $0.20 EPS. The July 23 announcement will reveal whether Intel meets that projection.





